Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 22025-03-24NCT06022003

2 results · Page 1 of 1

Swipe the table sideways for more columns.

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Amiens CHUAmiensFrance2
Angers CHUAngersFrance3
Bordeaux CHUPessacFrance3
Centre Antoine LacassagneNiceFrance60
Centre de Lutte Contre le Cancer H. BecquerelRouenFrance1
Chu EstaingClermont-FerrandFrance18
CHU LilleLilleFrance63
Créteil CHU HENRI MONDORCréteilFrance2
Grenoble CHUGrenobleFrance3
Hôpital d'Instruction des Armées PercyClamartFrance5
ICANS - Institut de cancérologie de strasbourg europeStrasbourgFrance3
Limoges CHULimogesFrance2
Lyon sud CHULyonFrance2
Marseille IPCMarseilleFrance3
Nancy CHUVandœuvre-lès-NancyFrance2
Nantes CHUNantesFrance3
Paris Saint LouisParisFrance2
Rennes CHURennesFrance2
Toulouse - IUCT Oncopole - Service d'HématologieToulouseFrance4
Versailles CHVersaillesFrance1